Overcoming challenges in conducting early phase breast cancer prevention trials: Bazedoxifene and conjugated estrogens vs waitlist control
2024 · Contemporary Clinical Trials · 0 citations
https://doi.org/10.1016/j.cct.2024.107697
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Kate Young is an academic researcher.
Click to start Chat